Search results for: knee

Drug Updates

Michele B. Kaufman, PharmD, BCGP | July 9, 2012

Information on new approvals and medication safety.

Minerals, Mud, Martinis, and Methylprednisone

Simon M. Helfgott, MD | June 10, 2012

How the practice of rheumatology differs in America and Europe.

Coding Corner: Incident-To

Staff | June 10, 2012

A 65-year-old female Medicare patient with rheumatoid arthritis sees a nonphysician provider for a followup visit.

Orthotics Part of Arthritis Treatment

Kurt Ullman | June 10, 2012

Although no cure, assistive devices can have an impact on pain of arthritis in the lower extremities

What’s In A Note?: The Use of Electronic Health Records

Simon M. Helfgott, MD | May 9, 2012

The dictum “to write as long as possible” has become the norm for some physicians. Quality, not quantity, should be our goal.

Basics of Biologic Joint Reconstruction

Andreas Gomoll, MD | April 6, 2012

For young patients especially, this can delay knee replacement and provide better outcomes.

New Osteoarthritis Recommendations and Classification Criteria for Sjögren’s Syndrome and Polymyalgia Rheumatica

Kathy Holliman | April 6, 2012

The ACR has published three documents intended to provide clarity and consensus on management of osteoarthritis, classification criteria for Sjögren’s syndrome, and classification criteria for polymyalgia rheumatica. The documents, which represent the most current clinical evidence, research, and expert panel input and review, can help inform clinical practice and provide clearer target populations for future research.

Association of Rheumatology Health Professionals (ARHP) Recognizes 2011 Graduate Student Award Recipients

Staff | April 6, 2012

The ARHP Graduate Student Award, established in 2006, is given annually to outstanding students in recognition of their research and clinical practice projects in the field of rheumatology. The ARHP is honored to recognize its 2011 Graduate Student Award recipients: Jennifer Mei Ping Woo and Andrew Galica.

Rheumatoid Arthritis Drugs May Cut Cardiovascular Risk

Kathleen Louden | April 6, 2012

Other studies at the ACR/ARHP Annual Scientific Meeting in November examined arthritis treatment, scleroderma screening.

The Mystery of IVIg

Eveline Wu, MD, Michael M. Frank, MD | March 8, 2012

Although initially given as replacement therapy for patients with primary and secondary immunodeficiency states, intravenous immunoglobulin (IVIg) has proven to be effective in the treatment of various autoimmune and inflammatory disorders. This success has led to a dramatic increase in the use of IVIg, with its use as an antiinflammatory agent now vastly surpassing its use in the treatment of immunodeficiencies. Even so, the basis for the antiinflammatory activity of IVIg remains unclear.